期刊文献+

乳腺癌新辅助化疗研究进展 被引量:18

原文传递
导出
摘要 随着对乳腺癌是一种全身性疾病的认识转变,乳腺癌的治疗重点亦从以往的手术治疗转向早期全身治疗的新模式,其中最重要的是新辅助化疗(neo—adjuvant chemotherapy,NCT)。一些大规模的临床试验也肯定了新辅助化疗在乳腺癌全身性综合治疗方面的价值。由于新辅助化疗实践的不断深入,对乳腺癌从基础到临床各方面有了更新的认识。
作者 刘晶晶 张瑾
出处 《中华乳腺病杂志(电子版)》 CAS 2012年第1期40-43,共4页 Chinese Journal of Breast Disease(Electronic Edition)
  • 相关文献

参考文献24

  • 1Garces CA,Cance WG. Neoadjuvant chemotherapy of breast cancer[J].American Surgeon,2004,(07):565-569.
  • 2Mamounes EP,Wang J,Bryant J. Patterns of locoregional failure (LRF) in patients receiving neoadjuvant chemotherapy (NC):results from NSABP-18[J].Breast Cancer Research and Treatment,2003,(Supple1):17-23.
  • 3惠锐,张瑾,范宇.乳腺癌新辅助化疗后病理缓解的临床意义[J].中华医学杂志,2008,88(14):961-964. 被引量:7
  • 4Co11eoni M,OrvietoE,Nolé F. Predictionof response to primary chemotherapy for operable breast cancer[J].European Journal of Cancer,1999,(04):574-579.
  • 5Gregory RK,Powles TJ,Salter J. Prugnostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy[J].Breast Cancer Research and Treatment,2000,(02):171-175.
  • 6Zhang F,Yang Y,Smith T. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil,doxorubicin,and cyclophosphamid in patients with breast carcinoma[J].Cancer,2003,(07):1758-1765.
  • 7Taucher S,Rudas M,Mader RM. Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer[J].Breast Cancer Research and Treatment,2003,(03):207-213.
  • 8Euler U,Tulusan AH. An attempt to identify biological markers predicting response to primary chemotherapy with epirubiein/cyclophosphamid in locally advance breast cancer[A].
  • 9Pohl G,Rudas M,Taucher S. Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy[J].Breast Cancer Research and Treatment,2003,(01):97-103.
  • 10Davis DW,Buchholz TA,Hess KR. Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer:early assessment predicts clinical response[J].Clinical Cancer Research,2003,(03):955-960.

二级参考文献15

  • 1Fisher ER, Wang J, Bryant J, et al. Pathobiology of preoperative chemotherapy : findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer, 2002,95:681-695.
  • 2Sataloff DM, Mason BA, Prestipino A J, et al. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. Am J Coil Surg, 1995,180: 297 -306.
  • 3Catherine A, lsabelle VP, Remi D, et al. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer. Oncologist, 2005, 10: 242-249.
  • 4Kuerer HM, Newman LA, Buzdar AU, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg, 1998,176:502-509.
  • 5Gajdos C, Tarrier PI, Estabrook A, et al. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol, 2002,80:4-11.
  • 6Chen AM, Meric-Bemstam F, Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol, 2004,22:2303-2312.
  • 7Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy : prognostic significance and survival. Breast, 2003, 12: 320-327.
  • 8Pu RT, Schott AF, Sturtz DE, et al. Pathologic features of breast cancer associated complete response to neoadjuvant chemotherapy: importance of tumor necrosis. Am J Surg Pathol, 2005, 29 : 354- 358.
  • 9Ilknur GB, Hilmi A, Tualy C, et al. The importance of extracapsular extension of axillary lymph node metastases in breast cancer. Tumori, 2004,90:107-111.
  • 10Meric F, Mirza NQ, Buzdar AU, et al. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3NOM0 breast cancer. Ann Surg Oncol, 2000, 7: 435-440.

共引文献43

同被引文献177

引证文献18

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部